# A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.

> **NCT00502736** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 13 (actual)

## Conditions studied

- Pain; Bone Neoplasms; Neoplasm Metastasis

## Interventions

- **DRUG:** ibandronate [Bondronat]

## Key facts

- **NCT ID:** NCT00502736
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2014-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00502736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00502736, "A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT00502736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*